fluoxetine has been researched along with 4-iodo-2,5-dimethoxyphenylisopropylamine in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 14 (50.00) | 18.2507 |
| 2000's | 8 (28.57) | 29.6817 |
| 2010's | 6 (21.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fone, KC; Marsden, CA; Robinson, AJ | 1 |
| Hrdina, PD; Mann, CD; Vu, TB | 1 |
| Friedman, E; Tilakaratne, N; Yang, Z | 1 |
| Berendsen, HH; Broekkamp, CL | 2 |
| Battaglia, G; Cabrera, TM | 1 |
| Baylis, PH; Butler, TJ; Charlton, JA; Faull, CM | 1 |
| Battaglia, G; Brownfield, MS; Cabrera, TM; Levy, AD; Li, Q; Rittenhouse, PA; van de Kar, LD | 1 |
| Hietala, J; Kuoppamäki, M; Laakso, A; Pälvimäki, EP; Syvälahti, E | 1 |
| Akpaudo, SB; Alkadhi, KA; Hogan, YH; Salgado-Commissariat, D | 1 |
| Bourin, M; Redrobe, JP | 1 |
| Battaglia, G; Li, Q; Muma, NA; Van de Kar, LD | 1 |
| Galis-de Graaf, Y; Mijnster, MJ; Voorn, P | 1 |
| Ashby, CR; Katsumori, H; Minabe, Y; Watanabe, K | 1 |
| Hietala, J; Majasuo, H; Pälvimäki, EP; Syvälahti, E | 1 |
| de Bortoli, VC; Nogueira, RL; Zangrossi, H | 1 |
| Chang, L; Greenstein, D; Klaff, J; Qu, Y; Rapoport, SI; Seemann, R | 1 |
| Battaglia, G; Carrasco, GA; Damjanoska, KJ; Garcia, F; Grippo, AJ; Landry, M; Muma, NA; Shi, J; Singh, RK; Sullivan, NR | 1 |
| Abdel-Magid, N; Azmitia, EC; El-Nour, H; Lonne-Rahm, SB; Lundeberg, L; Nordlind, K | 1 |
| Dai, XM; Lu, Y; Ma, HW; Yao, Y | 1 |
| Ewald, AH; Maurer, HH | 1 |
| Gulley, JM; Klein, DA | 1 |
| Ermani, M; Freo, U; Merico, A; Ori, C | 1 |
| Akagawa, K; Fujiwara, T; Kofuji, T; Snada, M; Yoshikawa, T | 1 |
| Egashira, N; Fujiwara, M; Iwasaki, K; Mishima, K; Nagao, M; Oishi, R; Okuno, R; Shirakawa, A | 1 |
| Bridgman, A; Creed, MC; Fletcher, PJ; Hamani, C; Nobrega, JN | 1 |
| Barragán-Iglesias, P; Bravo-Hernández, M; Cervantes-Durán, C; Granados-Soto, V; Pineda-Farias, JB; Quiñonez-Bastidas, GN; Vidal-Cantú, GC | 1 |
| Banas, SM; Belmer, A; Diaz, SL; Doly, S; Fernandez, SP; Guiard, BP; Mameli, M; Maroteaux, L; Moutkine, I; Muzerelle, A; Pitychoutis, PM; Quentin, E; Roumier, A; Tchenio, A | 1 |
28 other study(ies) available for fluoxetine and 4-iodo-2,5-dimethoxyphenylisopropylamine
| Article | Year |
|---|---|
Characterization of the 5-HT receptor subtypes involved in the motor behaviours produced by intrathecal administration of 5-HT agonists in rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamines; Animals; Clorgyline; Fluoxetine; Injections, Spinal; Ketanserin; Male; Motor Activity; Muscle Contraction; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin; Tetrahydronaphthalenes | 1991 |
Protein kinase C in rat brain cortex and hippocampus: effect of repeated administration of fluoxetine and desipramine.
Topics: Amphetamines; Animals; Antidepressive Agents; Autoradiography; Binding, Competitive; Cerebral Cortex; Desipramine; Fluoxetine; Hippocampus; Injections, Intraperitoneal; Male; Paraventricular Hypothalamic Nucleus; Phorbol 12,13-Dibutyrate; Protein Kinase C; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists; Signal Transduction | 1995 |
Chronic fluoxetine or desmethylimipramine treatment alters 5-HT2 receptor mediated c-fos gene expression.
Topics: Amphetamines; Animals; Antidepressive Agents, Tricyclic; Cerebral Cortex; Desipramine; Fluoxetine; Gene Expression; Genes, fos; Hippocampus; Ketanserin; Male; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; RNA; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Receptor Agonists | 1995 |
Comparison of stimulus properties of fluoxetine and 5-HT receptor agonists in a conditioned taste aversion procedure.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamines; Analysis of Variance; Animals; Avoidance Learning; Conditioning, Classical; Fluoxetine; Male; Mice; Paroxetine; Pyrazines; Serotonin Receptor Agonists; Taste | 1994 |
Delayed decreases in brain 5-hydroxytryptamine2A/2C receptor density and function in male rat progeny following prenatal fluoxetine.
Topics: Adrenocorticotropic Hormone; Amphetamines; Animals; Cerebral Cortex; Female; Fluoxetine; Hypothalamus; Male; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin Receptor Agonists; Weight Gain | 1994 |
The effect of acute pharmacological manipulation of central serotonin neurotransmission on osmoregulated secretion of arginine vasopressin in the rat.
Topics: Amphetamines; Animals; Arginine Vasopressin; Fluoxetine; Male; Rats; Rats, Wistar; Ritanserin; Secretory Rate; Serotonin; Serotonin Antagonists; Water-Electrolyte Balance | 1993 |
Long-term treatment with the antidepressants fluoxetine and desipramine potentiates endocrine responses to the serotonin agonists 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212) and (+-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane HCl (DOI).
Topics: Adrenocorticotropic Hormone; Amphetamines; Animals; Desipramine; Drug Synergism; Fluoxetine; Hormones; Ketanserin; Male; Pyrazines; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists; Vasopressins | 1993 |
Chronic citalopram and fluoxetine treatments upregulate 5-HT2c receptors in the rat choroid plexus.
Topics: Amphetamines; Animals; Antiparkinson Agents; Autoradiography; Choroid Plexus; Citalopram; Ergolines; Fluoxetine; Image Processing, Computer-Assisted; Male; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Up-Regulation | 1996 |
Induction and maintenance of ganglionic long-term potentiation require activation of 5-hydroxytryptamine (5-HT3) receptors.
Topics: Action Potentials; Amphetamines; Animals; Electrophysiology; Fluoxetine; In Vitro Techniques; Long-Term Potentiation; Male; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Superior Cervical Ganglion; Synaptic Transmission | 1996 |
Partial role of 5-HT2 and 5-HT3 receptors in the activity of antidepressants in the mouse forced swimming test.
Topics: Amphetamines; Animals; Antidepressive Agents; Behavior, Animal; Citalopram; Desipramine; Drug Interactions; Fluoxetine; Fluvoxamine; Imipramine; Ketanserin; Male; Maprotiline; Mice; Ondansetron; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Ritanserin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Swimming | 1997 |
Indirect in vivo 5-HT1A-agonistic effects of the new antidepressant mirtazapine.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamines; Animals; Antidepressive Agents, Tricyclic; Behavior, Animal; Conditioning, Operant; Fluoxetine; Male; Mianserin; Mice; Mice, Inbred ICR; Mirtazapine; Pyrazines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Taste | 1997 |
Fluoxetine gradually increases [125I]DOI-labelled 5-HT2A/2C receptors in the hypothalamus without changing the levels of Gq- and G11-proteins.
Topics: Amphetamines; Animals; Cerebral Cortex; Fluoxetine; GTP-Binding Proteins; Hypothalamus; Immunoblotting; Ketanserin; Male; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Receptor Agonists | 1997 |
Serotonergic regulation of neuropeptide and glutamic acid decarboxylase mRNA levels in the rat striatum and globus pallidus: studies with fluoxetine and DOI.
Topics: Amphetamines; Animals; Corpus Striatum; Fluoxetine; Globus Pallidus; Glutamate Decarboxylase; Injections, Intraperitoneal; Male; Neuropeptides; Rats; Rats, Wistar; RNA, Messenger; Serotonin; Serotonin Receptor Agonists | 1998 |
Effect of acute administration of various 5-HT receptor agonists on focal hippocampal seizures in freely moving rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamines; Animals; Behavior, Animal; Electric Stimulation; Electrodes, Implanted; Electroencephalography; Epilepsy, Complex Partial; Fluoxetine; Hippocampus; Kindling, Neurologic; Male; Piperidines; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists | 1998 |
Serotonin 5-HT2C receptor-mediated phosphoinositide hydrolysis in rat choroid plexus after fluoxetine and citalopram treatments.
Topics: Amphetamines; Animals; Choroid Plexus; Citalopram; Dose-Response Relationship, Drug; Ergolines; Fluoxetine; Hydrolysis; Inositol Phosphates; Male; Phosphatidylinositols; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Second Messenger Systems; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists | 2005 |
Effects of fluoxetine and buspirone on the panicolytic-like response induced by the activation of 5-HT1A and 5-HT2A receptors in the rat dorsal periaqueductal gray.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamines; Animals; Anti-Anxiety Agents; Buspirone; Fluoxetine; Male; Microinjections; Periaqueductal Gray; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Receptor Agonists | 2006 |
Chronic fluoxetine upregulates arachidonic acid incorporation into the brain of unanesthetized rats.
Topics: Amphetamines; Animals; Arachidonic Acid; Autoradiography; Brain; Brain Mapping; Drug Administration Routes; Drug Administration Schedule; Drug Interactions; Fluoxetine; Infusions, Intravenous; Male; Rats; Rats, Inbred F344; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Tritium; Up-Regulation; Wakefulness | 2006 |
Agonist induced-phosphorylation of Galpha11 protein reduces coupling to 5-HT2A receptors.
Topics: Amphetamines; Animals; Cell Culture Techniques; Cell Line; Fluoxetine; Frontal Lobe; GTP-Binding Protein alpha Subunits, Gq-G11; Ketanserin; Male; Phosphorylation; Protein Binding; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Agonists; Serotonin Receptor Agonists; Signal Transduction; Transfection; Type C Phospholipases | 2007 |
Serotonergic mechanisms in human allergic contact dermatitis.
Topics: Amphetamines; Blood Platelets; Cell Line; Cell Proliferation; Citalopram; Dermatitis, Allergic Contact; Fluoxetine; Humans; Immunohistochemistry; Interleukin-1beta; Interleukin-2; Irritants; Leukocytes, Mononuclear; Nickel; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Serotonin Receptor Agonists | 2007 |
[Roles of fluoxetine and haloperidol in mouse models of DOI-induced head twitch response].
Topics: Amphetamines; Animals; Disease Models, Animal; Dopamine; Fluoxetine; Haloperidol; Homovanillic Acid; Male; Mice; Receptor, Serotonin, 5-HT1A; Tourette Syndrome | 2007 |
2,5-Dimethoxyamphetamine-derived designer drugs: studies on the identification of cytochrome P450 (CYP) isoenzymes involved in formation of their main metabolites and on their capability to inhibit CYP2D6.
Topics: Algorithms; Amphetamines; Animals; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Designer Drugs; DOM 2,5-Dimethoxy-4-Methylamphetamine; Fluoxetine; Gas Chromatography-Mass Spectrometry; Humans; Hydroxylation; Insecta; Kinetics; Microsomes, Liver; Molecular Structure; Quinidine; Spectrometry, Mass, Electrospray Ionization | 2008 |
Reduced sensitivity to the locomotor-stimulant effects of cocaine is associated with increased sensitivity to its discriminative stimulus properties.
Topics: Amphetamines; Animals; Cocaine; Conditioning, Operant; Discrimination Learning; Dose-Response Relationship, Drug; Drug Combinations; Fluoxetine; Generalization, Stimulus; Motor Activity; Rats; Rats, Long-Evans; Reinforcement Schedule; Serotonin 5-HT2 Receptor Agonists; Serotonin Receptor Agonists | 2009 |
Chronic treatment with fluoxetine decreases cerebral metabolic responses to the 5-HT1A agonist 8-hydroxy-2(di-N-propylamino)tetralin and increases those to the 5-HT2A/2C agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane and to the dopaminergic agonist
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamines; Animals; Apomorphine; Brain; Dopamine Agonists; Down-Regulation; Drug Administration Schedule; Fluoxetine; Male; Rats; Rats, Inbred F344; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Up-Regulation | 2010 |
HPC-1/syntaxin 1A gene knockout mice show abnormal behavior possibly related to a disruption in 5-HTergic systems.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic Uptake Inhibitors; Amphetamines; Animals; Behavior, Animal; Desipramine; Dopamine Agonists; Dopamine Antagonists; Fluoxetine; Haloperidol; Hippocampus; Humans; Hypothalamus; Inhibition, Psychological; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Piperazines; Quinpirole; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Serotonin Receptor Agonists; Social Behavior; Syntaxin 1 | 2010 |
Role of 5-hydroxytryptamine2C receptors in marble-burying behavior in mice.
Topics: Aminopyridines; Amphetamines; Animals; Behavior, Animal; Fluoxetine; Indoles; Male; Mice; Mice, Inbred ICR; Motor Activity; Obsessive-Compulsive Disorder; Paroxetine; Receptor, Serotonin, 5-HT2C; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists | 2012 |
Contribution of decreased serotonin release to the antidyskinetic effects of deep brain stimulation in a rodent model of tardive dyskinesia: comparison of the subthalamic and entopeduncular nuclei.
Topics: 5,7-Dihydroxytryptamine; Amphetamines; Analysis of Variance; Animals; Antipsychotic Agents; Autoradiography; Benzylamines; Carbon Isotopes; Chromatography, High Pressure Liquid; Deep Brain Stimulation; Disease Models, Animal; Electrochemical Techniques; Entopeduncular Nucleus; Exploratory Behavior; Fluoxetine; Haloperidol; Hydroxyindoleacetic Acid; Male; Mastication; Microdialysis; Movement Disorders; Protein Binding; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Serotonin Receptor Agonists; Subthalamic Nucleus | 2012 |
Evidence for the participation of peripheral 5-HT₂A, 5-HT₂B, and 5-HT₂C receptors in formalin-induced secondary mechanical allodynia and hyperalgesia.
Topics: Amphetamines; Analgesics; Animals; Dose-Response Relationship, Drug; Female; Fluoxetine; Formaldehyde; Hyperalgesia; Ketanserin; p-Methoxy-N-methylphenethylamine; Pyrimidines; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Spiro Compounds; Sulfonamides | 2013 |
Positive regulation of raphe serotonin neurons by serotonin 2B receptors.
Topics: 3,4-Methylenedioxyamphetamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Action Potentials; Amphetamines; Animals; Body Temperature; Central Nervous System Sensitization; Female; Fluoxetine; Indoles; Male; Mice; Mice, Knockout; Mice, Transgenic; Neurogenesis; Prepulse Inhibition; Raphe Nuclei; Receptor, Serotonin, 5-HT2B; Serotonergic Neurons; Serotonin 5-HT2 Receptor Agonists; Thiophenes; Transcription Factors | 2018 |